At Inpart, our commitment to excellence, creativity, and purpose-driven initiatives fuel our mission to connect the right partners at the right time for the purpose of bringing science to the market faster.
About us
Our teams
Our shared goal is to facilitate powerful collaborations, bringing together industry leaders and pioneering researchers to unlock untapped potential. With a diverse background spanning multiple sectors, we come together with one vision: to help bring science to life. Our teams of STEM professionals and partnering experts are committed to guiding our clients toward excellence throughout the entire partnership life cycle.
Our values
Care
Foster responsible impact.
Excellence
Strive to deliver highest quality and value.
Diversity
Cultivate curiosity.
Index de l'égalité professionnalle femmes-hommes: 98/10
Mis à jour le 1 mars 2024
About us
Inpart is the trusted partner for biopharma and science partnering. We provide comprehensive solutions to facilitate, optimize and track interactions in the biopharma, scientific and academic sectors. Our technology is the preferred choice for more than 6,500 companies including 45/50 of the world's leading pharma companies, 25/25 global R&D intensive firms, 25/25 top EU R&D intensive firms and over 200 of the world’s leading universities.
Our cutting-edge match making platform, Connect, serves as the backbone of a thriving network, uniting over 6,500 industry professionals, academic organizations, Biotech companies and investors. Through Connect, we empower users to enhance their visibility, expedite partner discovery, and gain invaluable strategic insights.
Inpart's partnering CRM, Deal, is tailored specifically to meet the unique demands of the biopharma sector. Deal streamlines the collaboration and alliance management phases of biopharma partnerships, ensuring efficient and organized operations in executing Biopharma deals.
Inpart Event powers more than 50,000 partnering meetings annually at the world's most important biopharma partnering conferences, including the BIO International Convention.
Finally, with subsidiary Labiotech, a preeminent digital media, we engage with over 100,000 professionals in the life science sector monthly, delivering the latest relevant information from the industry, to the industry.
Seeking new partnerships?
Join a global network of decision-makers and research teams looking to partner with the latest research, assets and expertise.